Over 12 months, Bluejay Diagnostics, Inc. saw more buying than selling from its insiders — purchases of about $222,000 against sales of $49,000.
HRT FINANCIAL LP (10% Owner) made the biggest buy, worth around $97,000. Notably, at least one C-suite executive was among the buyers.
Looking at the quarterly pattern: Last full quarter: net buying by insiders. Insiders bought in 2 of the last 7 full quarters. Big money check: 8 institutions held BJDX as of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 64,047 | $1.51 | $97K | SEC |
| Jul 13, 2026 | HRT FINANCIAL LP | 10% Owner | Sell | 34,938 | $1.40 | $49K | SEC |
| May 18, 2026 | Wurth Douglas Clark | Director | Buy | 12,500 | $2.00 | $25K | SEC |
| May 18, 2026 | Dey Indranil | CEO | Buy | 12,500 | $2.00 | $25K | SEC |
| May 18, 2026 | CHASE DONALD R | Director | Buy | 12,500 | $2.00 | $25K | SEC |
| May 18, 2026 | ZEIDMAN FRED S | Director | Buy | 12,500 | $2.00 | $25K | SEC |
| May 18, 2026 | Dey Svetlana | Director | Buy | 12,500 | $2.00 | $25K | SEC |
| Dec 14, 2023 | Dey Svetlana | Director | Buy | 500 | $3.07 | $2K | SEC |
| Dec 14, 2023 | Dey Indranil | CEO | Buy | 500 | $3.27 | $2K | SEC |
| Mar 31, 2023 | Dey Svetlana | Director | Buy | 10,000 | $0.44 | $4K | SEC |
| Mar 31, 2023 | Dey Indranil | CEO | Buy | 2,000 | $0.44 | $880 | SEC |
| Mar 31, 2023 | Dey Indranil | CEO | Buy | 8,000 | $0.44 | $4K | SEC |
In the last 12 months Bluejay Diagnostics, Inc. insiders made open-market purchases worth about $222,000 and sales worth about $49,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in BJDX was filed on 2026-07-13.
8 investment managers reported holding BJDX in SEC Form 13F filings for Q2 2026.
No congressional trades in BJDX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).